S 4601·NJ·senate
Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.
Introduced
Sponsor: Vitale, Joseph F. (D)
Summary
The bill would obligate any pharmacist—or a person they designate—to inform a consumer if the medication they receive is a substitute for the drug or biological product originally prescribed. It aims to increase transparency for patients about what they are taking and why a substitution was made.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 4601 changes status, plus AI-powered summaries and stage predictions.
Sign up free